OSR Health, Inc. Receives Nasdaq Delisting Determination

What Happened
OSR Health, Inc. announced on August 19, 2026 that Nasdaq's Listing Qualifications staff issued a determination to delist the Company’s common stock and warrants from the Nasdaq Capital Market. Nasdaq notified the Company it is not in compliance with Listing Rule 5550(a)(2) (minimum $1.00 closing bid) and advised that trading in the stock and warrants will be suspended at the opening of business on August 26, 2026. OSR Health intends to request a hearing before a Nasdaq Hearings Panel by 4:00 p.m. Eastern Time on August 26, 2026.

Key Details

• Nasdaq found the Company out of compliance with Rule 5550(a)(2) (minimum $1.00 closing bid for securities).
• Nasdaq noted compliance would require a closing bid ≥ $1.00 for at least 10 consecutive trading days; the Company had compliance periods through August 31, 2026 but Nasdaq concluded compliance could not be achieved by then.
• Trading suspension is scheduled at the opening of business on August 26, 2026; Nasdaq will file Form 25‑NSE to remove the securities from listing/registration unless the Panel’s action prevents it.
• OSR Health will request a hearing by 4:00 p.m. ET on Aug 26, 2026; a timely hearing request will not prevent the trading suspension but is expected to stay the formal delisting filing pending the Panel’s decision. The Company’s warrants are subject to delisting because the underlying stock will no longer be listed.

Why It Matters
For investors, the immediate impact is a suspension of trading on Nasdaq starting Aug 26, 2026 and potential removal of the Company’s securities from Nasdaq if the Hearings Panel does not permit continued listing. Suspension and delisting reduce liquidity and change how shares and warrants can be traded (and the filing notes there is no assurance the hearing will preserve the listing). OSR Health has furnished a press release (Exhibit 99.1) announcing the delisting determination and its intent to seek a hearing; shareholders should monitor company filings and Nasdaq/Hearings developments for updates.